Credit: New Africa on Shutterstock
In A Nutshell
- Inhaled cannabis dramatically increased food intake in humans within 30 minutes, regardless of how long they had fasted or whether they were already full
- In rats, cannabis overrode satiety completely and boosted motivation to seek food even when animals had been fed to the point of fullness
- The munchies appear to work through the brain’s reward system, not hunger hormones, which could make cannabis useful for patients whose appetite signals have been compromised by illness or treatment
- Regular cannabis users in the human study still showed a clear appetite response, suggesting the effect does not easily diminish with habitual use
For decades, the munchies have been treated as a punchline, a predictable side effect of cannabis that leads to raided refrigerators and regrettable snack choices. A new study published in the Proceedings of the National Academy of Sciences argues the science behind that late-night hunger surge deserves far more serious attention. For patients struggling to eat due to cancer treatment, HIV, or anorexia nervosa, that same effect could be a meaningful clinical asset.
Researchers at the University of Calgary and Washington State University ran parallel experiments on human volunteers and rats to map exactly what cannabis does to appetite. They found inhaled cannabis produces a fast-acting increase in food consumption that held up across doses, biological sex, and, in the rat experiments, even when the animals were already full. The appetite-stimulating response is consistent and predictable, exactly the kind of profile that would make it worth pursuing in a clinical setting.
With roughly 4% of the world’s population using cannabis as of 2020, and legal access expanding rapidly across North America, the researchers argue a clear-eyed scientific understanding of the munchies is long overdue.
How the Study Was Conducted
On the human side, 82 participants, 37 women and 45 men, were randomly assigned to vaporize either a low-dose cannabis flower containing 20 mg of THC, a high-dose version with 40 mg of THC, or a placebo in a controlled laboratory setting. After roughly an hour of memory tests, participants were given free access to a variety of snacks and beverages, with researchers tracking how much they ate every 30 minutes.
Both cannabis doses produced the same result: within just 30 minutes, participants who had inhaled cannabis ate significantly more than those who got the placebo, with no meaningful difference between the low and high doses at that point. How long it had been since someone last ate made no difference either. Moderation analyses showed that fasting duration had no measurable influence on how much cannabis boosted intake.
One piece of conventional wisdom the study pushed back on: cannabis did not steer people toward specific foods. Carbohydrate, fat, and protein intake all increased proportionally, meaning the overall ratio of nutrients consumed was no different from the placebo condition. The idea that being high makes people crave sweets or carbs specifically did not hold up in healthy adults given unrestricted snack access.

What Rats Revealed About the Brain
To explore the biology in greater depth, the team exposed rats to cannabis vapor and measured their eating behavior under a range of conditions. Cannabis-exposed rats ate significantly more within the first 60 minutes, regardless of sex or what type of food was available.
Most telling was what happened when the rats were already full. Researchers fed the animals a satisfying meal before cannabis exposure, eliminating any biological reason to eat more. Cannabis vapor overrode that. Sated rats began eating just as eagerly as hungry ones, a response that points directly to why cannabis might help patients whose illness or treatment has dulled or eliminated their appetite signal.
Researchers also trained rats to press a lever an increasing number of times to earn a sugar pellet, a standard way of measuring how motivated an animal is to obtain a reward. Cannabis-exposed rats pressed harder, earned more pellets, and kept going even when the food was devalued, either by pre-feeding the animals to the point of fullness or by pairing the sugar with a chemical that causes nausea. What the operant data suggests is that cannabis increases the reward value of food and motivation to pursue it, even when the body has no pressing need for calories.
The Effect Comes From the Brain, Not Hunger Hormones
A natural question is whether cannabis stimulates appetite by triggering the body’s hunger hormones. Researchers measured a full panel of appetite-related hormones in rats after vapor exposure, including ghrelin, the hormone that signals hunger, along with several appetite-suppressing hormones such as leptin, insulin, and GLP-1. Cannabis did not significantly change any of them.
To pinpoint where the effect originates, the team used drugs to block cannabinoid receptors in two distinct ways. One compound blocked receptors throughout the entire body and brain. Another blocked only those receptors located outside the brain. When all cannabinoid receptors were blocked centrally, cannabis-driven overeating stopped. When only the peripheral receptors were blocked, the eating surge continued as normal.
That result draws a fairly clean line. Cannabis acts on receptors in the brain to increase the drive to seek and consume food, bypassing the body’s normal satiety signals in these experiments. It does not work through the gut. It does not work through hormones. It acts on the brain’s reward circuitry and reassigns the value of food upward.

Why This Matters for Patients Who Cannot Eat
Appetite loss is a serious medical problem. Patients undergoing chemotherapy frequently lose the desire to eat at a time when caloric intake is critical to tolerating treatment. People living with HIV can experience dangerous wasting. Patients with severe anorexia nervosa face life-threatening malnutrition. Existing appetite-stimulating medications often carry significant side effects or limited effectiveness.
Because cannabis acts on the brain’s reward system rather than hunger hormones, it does not require a person to feel hungry in order to work. In patients where those biological hunger signals have been compromised by illness or treatment, that distinction matters enormously. The researchers also note that regular cannabis users in the human cohort, who reported using roughly five times per week for approximately eight to ten years on average, still showed a clear appetite response, suggesting that even habitual users are not immune to the munchies.
Whether cannabis could be developed into a reliable clinical tool for appetite stimulation still requires dedicated research in patient populations. But what this study makes clear is that the munchies are not random or incidental. They follow a consistent, measurable biological mechanism, and that mechanism may have far more medical utility than anyone who ever laughed off the punchline has considered.
Disclaimer: This article is based on preclinical and controlled laboratory research. The findings should not be interpreted as medical advice. Cannabis remains a controlled substance in many jurisdictions, and its use for appetite stimulation in clinical populations has not been approved by the FDA. Consult a qualified healthcare provider before making any changes to your diet, treatment plan, or medication regimen.
Paper Notes
Limitations
Researchers were unable to measure blood THC levels in human participants, making it difficult to confirm exactly how much each person absorbed. The human portion of the study also could not include direct tests of satiety or food motivation comparable to the animal tasks, so the behavioral mechanisms identified in rats have not yet been confirmed in people. Because participants were experienced, regular cannabis users, the results may not apply equally to occasional or first-time users. The study also did not examine the long-term effects of chronic daily cannabis use on overall energy intake or body weight.
Funding and Disclosures
Funding came from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada, with operating funds held by Dr. Matthew Hill. Lead researcher Catherine Hume received postdoctoral fellowship support from the University of Calgary Eyes High program, the Hotchkiss Brain Institute, the Cumming School of Medicine, and the Alberta Children’s Hospital Research Institute. Samantha Baglot was supported by a CIHR Vanier Award and several additional Canadian research and Indigenous scholarships. Lucia Javorcikova received an Alberta Innovates Summer Research Studentship. Human study components were supported in part by funds from the State of Washington Initiative Measure No. 502, awarded to Carrie Cuttler and Ryan McLaughlin. McLaughlin also received NIH funding from NIDA and NIMH. The authors declared no competing interests.
Publication Details
Authors: Catherine Hume, Carrie Cuttler, Samantha L. Baglot, Lucia Javorcikova, Ryan J. McLaughlin, and Matthew N. Hill. Affiliations include the Department of Cell Biology and Anatomy, Psychiatry, and the Hotchkiss Brain Institute at the University of Calgary, Calgary, Alberta, Canada, and the Departments of Psychology and Integrative Physiology and Neuroscience at Washington State University, Pullman, Washington. | Journal: Proceedings of the National Academy of Sciences (PNAS) | Paper title: “Cannabis produces acute hyperphagia in humans and rodents via increased reward valuation for, and motivation to, acquire food” | Published: December 24, 2025 | Vol. 122, No. 52 | DOI: https://doi.org/10.1073/pnas.2518863122







